What is Emergent Biosolutions's free cash flow margin?

Emergent Biosolutions (EBS) reported free cash flow margin of 20.8% in Q1 2026.

What is the long-term trend for Emergent Biosolutions's free cash flow margin?

Over 2 years (2020 to 2025), Emergent Biosolutions's free cash flow margin has grown at a -7.2% compound annual growth rate (CAGR), from 25.4% to 21.9%.

What does free cash flow margin mean?

Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.

Emergent Biosolutions EBS Free cash flow margin

Free cash flow margin at other companies

Thermo Fisher ScientificTMO

15.7%-2.1pp

Regeneron PharmaceuticalsREGN

27.6%+5.5pp

AMP

Amphastar PharmaceuticalsAMPH

18.8%-1.8pp

Amneal Pharmaceuticals, Inc.AMRX

7.9%-1.0pp

CorMedixCRMD

48.7%+38.8pp

Collegium Pharmaceutical, Inc.COLL

41.4%+10.4pp

Other financials

Income statement

See full

Revenue$156.1M-29.7%

Gross profit$84.1M-37.1%

Operating income$10.5M-79.0%

Net income$6.8M-90.0%

EPS (diluted)$0.07-94.1%

Balance sheet

See full

Cash & equivalents$161.5M+5.7%

Total debt$584.6M-13.1%

Total equity$523.1M-5.4%

Total assets$1.3B-7.4%

Cash flow

See full

Operating cash flow-$33.8M-202%

CapEx$2.4M-33.3%

Free cash flow-$36.2M-145%

Valuation

See full

Market cap$411.74M+22.0%

Enterprise value$834.84M-2.6%

P/E3.6×—

P/S0.6×+0.3×

Profitability

See full

Gross margin54.2%+19.0pp

Operating margin15%+10.3pp

Net margin9.6%+5.8pp

Returns & leverage

See full

Return on equity13.9%+8.1pp

Debt / equity1.1×-0.1×

Current ratio4.3×-2.0×

Where this comes from

Calculated from Emergent Biosolutions’s reported figures.

free cash flow/total revenue=20.8%

Based on trailing twelve months.

The official record: Emergent Biosolutions’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Emergent Biosolutions's free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Emergent Biosolutions's free cash flow margin?: Emergent Biosolutions (EBS) reported free cash flow margin of 20.8% in Q1 2026.
What is the long-term trend for Emergent Biosolutions's free cash flow margin?: Over 2 years (2020 to 2025), Emergent Biosolutions's free cash flow margin has grown at a -7.2% compound annual growth rate (CAGR), from 25.4% to 21.9%.
What does free cash flow margin mean?: Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.